| Year |
Citation |
Score |
| 2022 |
Hu J, Yao J, Dseng S, Balasubramanian R, Jiménez MC, Li J, Guo X, Cruz DE, Gao Y, Huang T, Zeleznik OA, Ngo D, Liu S, Rosal MC, Nassir R, ... Paynter NP, et al. Differences in Metabolomic Profiles Between Black and White Women and Risk of Coronary Heart Disease: an Observational Study of Women From Four US Cohorts. Circulation Research. 101161CIRCRESAHA1213. PMID 36052690 DOI: 10.1161/CIRCRESAHA.121.320134 |
0.428 |
|
| 2020 |
Chandler PD, Balasubramanian R, Paynter N, Giulianini F, Fung T, Tinker LF, Snetselaar L, Liu S, Eaton C, Tobias DK, Tabung FK, Manson JE, Giovannucci EL, Clish C, Rexrode KM. Metabolic signatures associated with Western and Prudent dietary patterns in women. The American Journal of Clinical Nutrition. PMID 32520313 DOI: 10.1093/Ajcn/Nqaa131 |
0.304 |
|
| 2020 |
Solomon DH, Glynn RJ, Karlson EW, Lu F, Corrigan C, Colls J, Xu C, MacFadyen J, Barbhaiya M, Berliner N, Dellaripa PF, Everett BM, Pradhan AD, Hammond SP, Murray M, ... ... Paynter NP, et al. Adverse Effects of Low-Dose Methotrexate: A Randomized Trial. Annals of Internal Medicine. PMID 32066146 DOI: 10.7326/M19-3369 |
0.321 |
|
| 2019 |
Solomon DH, Shao M, Wolski K, Nissen S, Husni ME, Paynter N. Derivation and Validation of a Major Toxicity Risk Score Among NSAID Users Based on Data from a Randomized Controlled Trial. Arthritis & Rheumatology (Hoboken, N.J.). PMID 30801994 DOI: 10.1002/Art.40870 |
0.367 |
|
| 2019 |
Hu J, Balasubramanian R, Li J, Clish CB, Paynter NP, Albert CM, Liu S, Rosal MC, Nassir R, Rexrode KM. Abstract MP55: Racial Differences in Metabolomic Profiles Between African Americans and Whites in the Women’s Health Initiative Circulation. 139. DOI: 10.1161/Circ.139.Suppl_1.Mp55 |
0.309 |
|
| 2018 |
Xu H, Qian J, Paynter NP, Zhang X, Whitcomb BW, Tworoger SS, Rexrode KM, Hankinson SE, Balasubramanian R. Estimating the receiver operating characteristic curve in matched case control studies. Statistics in Medicine. PMID 30467878 DOI: 10.1002/Sim.7986 |
0.338 |
|
| 2018 |
Leening MJG, Cook NR, Franco OH, Manson JE, Lakshminarayan K, LaMonte MJ, Leira EC, Robinson JG, Ridker PM, Paynter NP. Comparison of Cardiovascular Risk Factors for Coronary Heart Disease and Stroke Type in Women. Journal of the American Heart Association. 7: e007514. PMID 30371339 DOI: 10.1161/Jaha.117.007514 |
0.404 |
|
| 2018 |
Pradhan AD, Paynter NP, Everett BM, Glynn RJ, Amarenco P, Elam M, Ginsberg H, Hiatt WR, Ishibashi S, Koenig W, Nordestgaard BG, Fruchart JC, Libby P, Ridker PM. Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study. American Heart Journal. 206: 80-93. PMID 30342298 DOI: 10.1016/J.Ahj.2018.09.011 |
0.378 |
|
| 2018 |
Mora S, Wenger NK, Cook NR, Liu J, Howard BV, Limacher MC, Liu S, Margolis KL, Martin LW, Paynter NP, Ridker PM, Robinson JG, Rossouw JE, Safford MM, Manson JE. Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women's Health Initiative. Jama Internal Medicine. PMID 30039172 DOI: 10.1001/Jamainternmed.2018.2875 |
0.435 |
|
| 2018 |
Paynter NP, Balasubramanian R, Giulianini F, Wang DD, Tinker LF, Gopal S, Deik AA, Bullock K, Pierce KA, Scott J, Martínez-González MA, Estruch R, Manson JE, Cook NR, Albert CM, et al. Metabolic Predictors of Incident Coronary Heart Disease in Women. Circulation. 137: 841-853. PMID 29459470 DOI: 10.1161/Circulationaha.117.029468 |
0.391 |
|
| 2018 |
Berkelmans GFN, Franzen S, Eliasson B, Visseren FLJ, Gudbjornsdottir S, Wild S, Van Der Graaf Y, Svensson AM, Read S, Paynter NP, Dorresteijn JAN. P1533Dealing with missing patient characteristics in clinical practice when using cardiovascular prediction models European Heart Journal. 39. DOI: 10.1093/Eurheartj/Ehy565.P1533 |
0.306 |
|
| 2017 |
Cook NR, Demler OV, Paynter NP. Clinical risk reclassification at 10 years. Statistics in Medicine. 36: 4498-4502. PMID 29156504 DOI: 10.1002/Sim.7340 |
0.309 |
|
| 2017 |
Paynter NP. Cardiovascular Risk Prediction: Widening the Net. Circulation Research. 121: 1032-1033. PMID 29025755 DOI: 10.1161/Circresaha.117.311868 |
0.427 |
|
| 2017 |
Sparks JA, Barbhaiya M, Karlson EW, Ritter SY, Raychaudhuri S, Corrigan CC, Lu F, Selhub J, Chasman DI, Paynter NP, Ridker PM, Solomon DH. Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study. Seminars in Arthritis and Rheumatism. PMID 28284844 DOI: 10.1016/J.Semarthrit.2017.02.003 |
0.311 |
|
| 2016 |
Paynter NP, Cook NR. Adding tests to risk based guidelines: evaluating improvements in prediction for an intermediate risk group. Bmj (Clinical Research Ed.). 354: i4450. PMID 27604897 DOI: 10.1136/Bmj.I4450 |
0.384 |
|
| 2016 |
Dugani SB, Akinkuolie AO, Paynter N, Glynn RJ, Ridker PM, Mora S. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus Secondary Analysis of a Randomized Clinical Trial. Jama Cardiology. 1: 136-145. PMID 27347563 DOI: 10.1001/Jamacardio.2016.0096 |
0.345 |
|
| 2016 |
Harada PH, Cook NR, Cohen DE, Paynter NP, Rose L, Ridker PM. Relation of Alanine Aminotransferase Levels to Cardiovascular Events and Statin Efficacy. The American Journal of Cardiology. 118: 49-55. PMID 27317931 DOI: 10.1016/J.Amjcard.2016.04.012 |
0.429 |
|
| 2016 |
Paynter NP, Ridker PM, Chasman DI. Are Genetic Tests for Atherosclerosis Ready for Routine Clinical Use? Circulation Research. 118: 607-19. PMID 26892961 DOI: 10.1161/Circresaha.115.306360 |
0.318 |
|
| 2015 |
Paynter NP, Kiefe CI, Lewis CE, Loria CM, Goff DC, Lloyd-Jones DM. Accumulation of metabolic cardiovascular risk factors in black and white young adults over 20 years. Journal of the American Heart Association. 4. PMID 25911605 DOI: 10.1161/Jaha.114.001548 |
0.419 |
|
| 2015 |
Cornelis MC, Byrne EM, Esko T, Nalls MA, Ganna A, Paynter N, Monda KL, Amin N, Fischer K, Renstrom F, Ngwa JS, Huikari V, Cavadino A, Nolte IM, et al. Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption. Molecular Psychiatry. 20: 647-56. PMID 25288136 DOI: 10.1038/Mp.2014.107 |
0.427 |
|
| 2015 |
Horne BD, Anderson JL, Muhlestein JB, Ridker PM, Paynter NP. Complete blood count risk score and its components, including RDW, are associated with mortality in the JUPITER trial. European Journal of Preventive Cardiology. 22: 519-26. PMID 24403296 DOI: 10.1177/2047487313519347 |
0.42 |
|
| 2014 |
Paynter NP, LaMonte MJ, Manson JE, Martin LW, Phillips LS, Ridker PM, Robinson JG, Cook NR. Comparison of lifestyle-based and traditional cardiovascular disease prediction in a multiethnic cohort of nonsmoking women. Circulation. 130: 1466-73. PMID 25156990 DOI: 10.1161/Circulationaha.114.012069 |
0.445 |
|
| 2014 |
Akinkuolie AO, Paynter NP, Padmanabhan L, Mora S. High-density lipoprotein particle subclass heterogeneity and incident coronary heart disease. Circulation. Cardiovascular Quality and Outcomes. 7: 55-63. PMID 24248942 DOI: 10.1161/Circoutcomes.113.000675 |
0.312 |
|
| 2014 |
Paynter NP, Everett BM, Cook NR. Cardiovascular disease risk prediction in women: is there a role for novel biomarkers? Clinical Chemistry. 60: 88-97. PMID 24100805 DOI: 10.1373/Clinchem.2013.202796 |
0.439 |
|
| 2013 |
Mazer NA, Giulianini F, Paynter NP, Jordan P, Mora S. A comparison of the theoretical relationship between HDL size and the ratio of HDL cholesterol to apolipoprotein A-I with experimental results from the Women's Health Study. Clinical Chemistry. 59: 949-58. PMID 23426429 DOI: 10.1373/Clinchem.2012.196949 |
0.332 |
|
| 2013 |
Lillegraven S, Paynter N, Prince FH, Shadick NA, Haavardsholm EA, Frits ML, Iannaccone CK, Kvien TK, Weinblatt ME, Solomon DH. Performance of matrix-based risk models for rapid radiographic progression in a cohort of patients with established rheumatoid arthritis. Arthritis Care & Research. 65: 526-33. PMID 23044765 DOI: 10.1002/Acr.21870 |
0.387 |
|
| 2013 |
Paynter NP, Cook NR. A bias-corrected net reclassification improvement for clinical subgroups. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 33: 154-62. PMID 23042826 DOI: 10.1177/0272989X12461856 |
0.343 |
|
| 2013 |
Lillegraven S, Paynter N, Prince F, Shadick N, Haavardsholm E, Frits M, Iannaccone C, Kvien T, Weinblatt M, Solomon D. FRI0445 The performance of matrix-based risk models for rapid radiographic progression in an observational cohort of established rheumatoid arthritis patients: Annals of the Rheumatic Diseases. 71: 465.1-465. DOI: 10.1136/Annrheumdis-2012-Eular.2902 |
0.346 |
|
| 2012 |
Cook NR, Paynter NP, Manson JE, Martin LW, Robinson JG, Wassertheil-Smoller S, Ridker PM. Clinical utility of lipoprotein-associated phospholipase A₂ for cardiovascular disease prediction in a multiethnic cohort of women. Clinical Chemistry. 58: 1352-63. PMID 22859728 DOI: 10.1373/Clinchem.2012.188870 |
0.427 |
|
| 2012 |
Cook NR, Paynter NP, Eaton CB, Manson JE, Martin LW, Robinson JG, Rossouw JE, Wassertheil-Smoller S, Ridker PM. Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic Women's Health Initiative. Circulation. 125: 1748-56, S1-11. PMID 22399535 DOI: 10.1161/Circulationaha.111.075929 |
0.448 |
|
| 2012 |
Paynter NP, Crainiceanu CM, Sharrett AR, Chambless LE, Coresh J. Effect of correcting for long-term variation in major coronary heart disease risk factors: relative hazard estimation and risk prediction in the Atherosclerosis Risk in Communities Study. Annals of Epidemiology. 22: 191-7. PMID 22221585 DOI: 10.1016/J.Annepidem.2011.12.001 |
0.516 |
|
| 2012 |
Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, ... ... Paynter NP, et al. Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 125: 188-97. PMID 22215894 DOI: 10.1161/Cir.0B013E3182456D46 |
0.31 |
|
| 2012 |
Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, ... ... Paynter NP, et al. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 125: e2-e220. PMID 22179539 DOI: 10.1161/Cir.0B013E31823Ac046 |
0.305 |
|
| 2012 |
Paynter NP, Mazer NA, Cook NR. Cardiovascular risk evaluation tools specific to population with diabetes - Reply Archives of Internal Medicine. 172: 524. DOI: 10.1001/Archinternmed.2012.49 |
0.347 |
|
| 2011 |
Lee TC, Glynn RJ, Peña JM, Paynter NP, Conen D, Ridker PM, Pradhan AD, Buring JE, Albert MA. Socioeconomic status and incident type 2 diabetes mellitus: data from the Women's Health Study. Plos One. 6: e27670. PMID 22194788 DOI: 10.1371/Journal.Pone.0027670 |
0.327 |
|
| 2011 |
Dorresteijn JA, Visseren FL, Ridker PM, Paynter NP, Wassink AM, Buring JE, van der Graaf Y, Cook NR. Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects. European Heart Journal. 32: 2962-9. PMID 22090661 DOI: 10.1093/Eurheartj/Ehr423 |
0.401 |
|
| 2011 |
Paynter NP, Mazer NA, Pradhan AD, Gaziano JM, Ridker PM, Cook NR. Cardiovascular risk prediction in diabetic men and women using hemoglobin A1c vs diabetes as a high-risk equivalent. Archives of Internal Medicine. 171: 1712-8. PMID 21788538 DOI: 10.1001/Archinternmed.2011.351 |
0.403 |
|
| 2011 |
Cook NR, Paynter NP. Performance of reclassification statistics in comparing risk prediction models. Biometrical Journal. Biometrische Zeitschrift. 53: 237-58. PMID 21294152 DOI: 10.1002/Bimj.201000078 |
0.307 |
|
| 2011 |
Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, ... ... Paynter NP, et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation. 123: e18-e209. PMID 21160056 DOI: 10.1161/Cir.0B013E3182009701 |
0.303 |
|
| 2011 |
Paynter NP. Does the 9p21 Genetic Variant Have a Role in Cardiovascular Risk Prediction? Current Cardiovascular Risk Reports. 5: 159-164. DOI: 10.1007/S12170-010-0150-4 |
0.42 |
|
| 2010 |
Cook NR, Paynter NP. Genetics and breast cancer risk prediction--are we there yet? Journal of the National Cancer Institute. 102: 1605-6. PMID 20956781 DOI: 10.1093/Jnci/Djq413 |
0.38 |
|
| 2010 |
Paynter NP, Sharrett AR, Louis TA, Rosamond W, Folsom AR, Coresh J. Paired comparison of observed and expected coronary heart disease rates over 12 years from the Atherosclerosis Risk in Communities Study. Annals of Epidemiology. 20: 683-90. PMID 20696408 DOI: 10.1016/J.Annepidem.2010.05.016 |
0.476 |
|
| 2010 |
Paynter NP, Chasman DI, Paré G, Buring JE, Cook NR, Miletich JP, Ridker PM. Association between a literature-based genetic risk score and cardiovascular events in women. Jama. 303: 631-7. PMID 20159871 DOI: 10.1001/Jama.2010.119 |
0.424 |
|
| 2010 |
Paynter NP, Chasman DI, Ridker PM. Genetic risk score and cardiovascular events in women: Reply Jama - Journal of the American Medical Association. 303: 2032-2033. DOI: 10.1001/Jama.2010.661 |
0.403 |
|
| 2009 |
Paynter NP, Cook NR, Everett BM, Sesso HD, Buring JE, Ridker PM. Prediction of incident hypertension risk in women with currently normal blood pressure. The American Journal of Medicine. 122: 464-71. PMID 19375556 DOI: 10.1016/J.Amjmed.2008.10.034 |
0.362 |
|
| 2009 |
Paynter NP, Chasman DI, Buring JE, Shiffman D, Cook NR, Ridker PM. Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Annals of Internal Medicine. 150: 65-72. PMID 19153409 DOI: 10.7326/0003-4819-150-2-200901200-00003 |
0.375 |
|
| 2008 |
Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation. 118: 2243-51, 4p followin. PMID 18997194 DOI: 10.1161/Circulationaha.108.814251 |
0.428 |
|
| 2008 |
Fox CS, Pencina MJ, Wilson PW, Paynter NP, Vasan RS, D'Agostino RB. Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study. Diabetes Care. 31: 1582-4. PMID 18458146 DOI: 10.2337/Dc08-0025 |
0.361 |
|
| 2007 |
Selvin E, Paynter NP, Erlinger TP. The effect of weight loss on C-reactive protein: a systematic review. Archives of Internal Medicine. 167: 31-9. PMID 17210875 DOI: 10.1001/Archinte.167.1.31 |
0.391 |
|
| 2006 |
Paynter NP, Yeh HC, Voutilainen S, Schmidt MI, Heiss G, Folsom AR, Brancati FL, Kao WH. Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: the atherosclerosis risk in communities study. American Journal of Epidemiology. 164: 1075-84. PMID 16982672 DOI: 10.1093/Aje/Kwj323 |
0.352 |
|
| 2005 |
Paynter N, Crainiceanu C, Sharrett AR, Chambless L, Coresh J. 097-S: Regression Dilution in Coronary Heart Disease Risk Prediction American Journal of Epidemiology. 161. DOI: 10.1093/Aje/161.Supplement_1.S25 |
0.495 |
|
| 2004 |
Paynter N, Watkins S. Telomere length: an independent risk factor for premature MI? Arteriosclerosis, Thrombosis, and Vascular Biology. 23: 1704; author reply 1. PMID 12972463 DOI: 10.1161/01.Atv.0000087621.49739.48 |
0.364 |
|
| 2003 |
Novielli KD, Simpson Z, Hua G, Diamond JJ, Sultana C, Paynter N. Urinary incontinence in primary care: a comparison of older African-American and Caucasian women. International Urology and Nephrology. 35: 423-8. PMID 15160551 DOI: 10.1023/B:Urol.0000022868.73066.9A |
0.309 |
|
| Show low-probability matches. |